B-type natriuretic peptide and its precursor in cardiac venous blood from failing hearts

European Journal of Heart Failure

Volumn 7, Issue 1, 2005, Pages 69-74

  Goetze, Jens Peter ^a,b   Rehfeld, Jens F ^b   Videbaek, Regitze ^a   Friis Hansen, Lennart ^b   Kastrup, Jens ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

B type natriuretic peptide; Cardiac secretion; Heart failure; Natriuretic peptide; proBNP

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE 32; PROTEIN PRECURSOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; CORONARY SINUS; DISEASE MARKER; FEMALE; HEART BLOOD VESSEL; HEART CATHETERIZATION; HEART DISEASE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PROCESSING; PROTEIN SECRETION; RADIOIMMUNOASSAY; VENOUS BLOOD;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; HEART ATRIA; HEART CATHETERIZATION; HEART FAILURE, CONGESTIVE; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NERVE TISSUE PROTEINS; PEPTIDE FRAGMENTS; PULMONARY ARTERY; SEVERITY OF ILLNESS INDEX; VENA CAVA, INFERIOR;

EID: 11844288336     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2004.04.012     Document Type: Article

References (30)

1. De Lemos J.A., McGuire D.K., Drazner M.H. B-type natriuretic peptide in cardiovascular disease. Lancet. 362:2003;316-322
2. Hunt P.J., Yandle T.G., Nicholls M.G., Richards A.M., Espiner E.A. The amino-terminal portion of pro-brain natriuretic peptide (Pro-BNP) circulates in human plasma. Biochem Biophys Res Commun. 214:1995;1175-1183
3. Schulz H., Langvik T.A., Lund S.E., Smith J., Ahmadi N., Hall C. Radioimmunoassay for N-terminal probrain natriuretic peptide in human plasma. Scand J Clin Lab Invest. 61:2001;33-42
4. Goetze J.P., Kastrup J., Pedersen F., Rehfeld J.F. Quantification of pro-B-type natriuretic peptide and its products in human plasma by use of an analysis independent of precursor processing. Clin Chem. 48:2002;1035-1042
5. Hunt P.J., Richards A.M., Nicholls M.G., Yandle T.G., Doughty R.N., Espiner E.A. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin Endocrinol (Oxf). 47:1997;287-296
6. Troughton R.W., Frampton C.M., Yandle T.G., Espiner E.A., Nicholls M.G., Richards A.M. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet. 355:2000;1126-1130
7. Bay M., Kirk V., Parner J., et al. NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function. Heart. 89:2003;150-154
8. Gardner R.S., Ozalp F., Murday A.J., Robb S.D., McDonagh T.A. N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J. 24:2003;1735-1743
9. Hunt P.J., Espiner E.A., Nicholls M.G., Richards A.M., Yandle T.G. The role of the circulation in processing pro-brain natriuretic peptide (proBNP) to amino-terminal BNP and BNP-32. Peptides. 18:1997;1475-1481
10. Downie P.F., Talwar S., Squire I.B., Davies J.E., Barnett D.B., Ng L.L. Assessment of the stability of N-terminal pro-brain natriuretic peptide in vitro: implications for assessment of left ventricular dysfunction. Clin Sci (Lond). 97:1999;255-258
11. Pemberton C.J., Johnson M.L., Yandle T.G., Espiner E.A. Deconvolution analysis of cardiac natriuretic peptides during acute volume overload. Hypertension. 36:2000;355-359
12. de Bold A.J., Bruneau B.G., Kuroski de Bold M.L. Mechanical and neuroendocrine regulation of the endocrine heart. Cardiovasc Res. 31:1996;7-18
13. Christoffersen C., Goetze J.P., Bartels E.D., et al. Chamber-dependent expression of brain natriuretic peptide and its mRNA in normal and diabetic pig heart. Hypertension. 40:2002;54-60
14. Wu F., Yan W., Pan J., Morser J., Wu Q. Processing of pro-atrial natriuretic peptide by corin in cardiac myocytes. J Biol Chem. 277:2002;16900-16905
15. Yan W., Wu F., Morser J., Wu Q. Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme. Proc Natl Acad Sci USA. 97:2000;8525-8529
16. Takemura G., Takatsu Y., Doyama K., et al. Expression of atrial and brain natriuretic peptides and their genes in hearts of patients with cardiac amyloidosis. J Am Coll Cardiol. 31:1998;754-765
17. Wiese S., Breyer T., Dragu A., et al. Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin II and diastolic fiber length. Circulation. 102:2000;3074-3079
18. Mukoyama M., Nakao K., Hosoda K., et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest. 87:1991;1402-1412
19. Mizuno Y., Yoshimura M., Yasue H., et al. Aldosterone production is activated in failing ventricle in humans. Circulation. 103:2001;72-77
20. Kalra P.R., Clague J.R., Bolger A.P., et al. Myocardial production of C-type natriuretic peptide in chronic heart failure. Circulation. 107:2003;571-573
21. Seidler T., Pemberton C., Yandle T., Espiner E., Nicholls G., Richards M. The amino terminal regions of proBNP and proANP oligomerise through leucine zipper-like coiled-coil motifs. Biochem Biophys Res Commun. 255:1999;495-501
22. Shimizu H., Masuta K., Asada H., Sugita K., Sairenji T. Characterization of molecular forms of probrain natriuretic peptide in human plasma. Clin Chim Acta. 334:2003;233-239
23. Nishikimi T., Yoshihara F., Morimoto A., et al. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertensnio. Hypertension. 28:1996;22-30
24. Clerico A., Del Ry S., Maffei S., Prontera C., Emdin M., Gianessi D. The circulating levels of cardiac natriuretic hormones in healthy adults: effects of age and sex. Clin Chem Lab Med. 40:2002;371-377
25. Redfield M.M., Rodefelder R.J., Jacobsen S.J., Mahoney D.W., Bailey K.R., Burnett J.C. Jr. Plasma brain natriuretic peptide concentration: Impact of age and gender. J Am Coll Cardiol. 40:2002;976-982
26. Rehfeld J.F., Goetze J.P. The posttranslational phase of gene expression: new possibilities in molecular diagnosis. Curr Mol Med. 3:2003;25-38
27. Goetze J.P., Christoffersen C., Perko M., et al. Increased cardiac BNP expression associated with myocardial ischemia. FASEB J. 17:2003;1105-1107
28. Goetze J.P., Kastrup J., Rehfeld J.F. The paradox of increased natriuretic hormones in congestive heart failure patients: does the endocrine heart also fail in heart failure? Eur Heart J. 24:2003;1471-1472
29. Goetze J.P., Videbaek R., Boesgaard S., Aldershvile J., Rehfeld J.F., Carlsen J. Pro-brain natriuretic peptide as marker of cardiovascular or pulmonary causes of dyspnea in patients with terminal parenchymal lung disease. J Heart Lung Transplant. 23:2004;80-87
30. Richards A.M., Nicholls M.G., Espiner E.A., et al. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation. 107:2003;2786-2792